Lv1
30 积分 2024-06-25 加入
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
1天前
已完结
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
5天前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
1个月前
已完结
皖公网安备34019202002308
